Heterogeneity Among the Acute Nonlymphocytic Leukemias: Value of Immunophenotype for Diagnosis, Prognosis, and Therapy
Willem A. Kamps(Pediatric Oncology Group), G. Bennett Humphrey(St. Jude Children's Research Hospital)
Cited by 3
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599